Eloxx Pharmaceuticals, Inc.
ELOXD
OTC PK
| 03/31/2026 | 03/31/2025 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.36M | 111.00K | 4.33M | 4.90M | 19.21M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 31.00K | -- | 458.00K | 672.00K | 93.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.11M | -- | 593.00K | 827.00K | 829.00K |
| Total Current Assets | 8.50M | -- | 5.38M | 6.40M | 20.13M |
|
|
|||||
| Total Current Assets | 8.50M | -- | 5.38M | 6.40M | 20.13M |
| Net Property, Plant & Equipment | -- | -- | 611.00K | 797.00K | 994.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.50M | -- | 5.99M | 7.20M | 21.12M |
|
|
|||||
| Total Accounts Payable | 3.03M | -- | 3.12M | 2.43M | 3.02M |
| Total Accrued Expenses | 1.24M | -- | 2.75M | 2.23M | 2.80M |
| Short-term Debt | 11.82M | -- | 12.54M | 12.54M | 12.54M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 2.77M | 2.20M | 4.69M |
| Total Finance Division Other Current Liabilities | -- | -- | 75.00K | 58.00K | 45.00K |
| Total Other Current Liabilities | -- | -- | 75.00K | 58.00K | 45.00K |
| Total Current Liabilities | 16.09M | -- | 21.25M | 19.46M | 23.09M |
|
|
|||||
| Total Current Liabilities | 16.09M | -- | 21.25M | 19.46M | 23.09M |
| Long-Term Debt | -- | -- | 3.33M | 4.03M | 8.56M |
| Short-term Debt | 11.82M | -- | 12.54M | 12.54M | 12.54M |
| Capital Leases | -- | -- | 4.00K | 6.00K | 135.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.09M | -- | 24.59M | 23.49M | 31.78M |
|
|
|||||
| Common Stock & APIC | 296.75M | -- | 266.40M | 264.33M | 263.73M |
| Retained Earnings | -304.33M | -- | -284.96M | -280.62M | -274.39M |
| Treasury Stock & Other | -- | -- | -41.00K | -- | -- |
| Total Common Equity | -7.58M | -24.34M | -18.60M | -16.29M | -10.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.58M | -24.34M | -18.60M | -16.29M | -10.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.58M | -24.34M | -18.60M | -16.29M | -10.66M |
|
|
|||||